1. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002; 155:487–495.
Article
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240:622–630.
Article
3. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8:1–21.
Article
4. Niemeier A, Schinke T, Heeren J, Amling M. The role of apolipoprotein E in bone metabolism. Bone. 2012; 50:518–524.
Article
5. Shin MH, Choi JS, Rhee JA, Lee YH, Nam HS, Jeong SK, et al. APOE polymorphism and carotid atherosclerosis in Korean population: the Dong-gu Study and the Namwon Study. Atherosclerosis. 2014; 232:180–185.
Article
6. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res. 1997; 12:1438–1445.
Article
7. Peter I, Crosier MD, Yoshida M, Booth SL, Cupples LA, Dawson-Hughes B, et al. Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a metaanalysis. Osteoporos Int. 2011; 22:1199–1209.
Article
8. Kweon SS, Shin MH, Jeong SK, Nam HS, Lee YH, Park KS, et al. Cohort Profile: The Namwon Study and the Dong-gu Study. Int J Epidemiol. 2014; 43:558–567.
Article
9. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990; 31:545–548.
Article
10. Shin MH, Kim HN, Cui LH, Kweon SS, Park KS, Heo H, et al. The effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci. 2005; 20:361–366.
Article
11. Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, et al. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss. J Bone Miner Res. 2000; 15:308–314.
Article
12. Zajícková K, Zofková I, Hill M, Horínek A, Nováková A. Apolipoprotein E 4 allele is associated with low bone density in postmenopausal women. J Endocrinol Invest. 2003; 26:312–315.
Article
13. Pluijm SM, Dik MG, Jonker C, Deeg DJ, van Kamp GJ, Lips P. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int. 2002; 13:701–709.
Article
14. Dick IM, Devine A, Marangou A, Dhaliwal SS, Laws S, Martins RN, et al. Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone. 2002; 31:497–502.
Article
15. Lee SI, Lee SY, Yoo WH. Association of apolipoprotein E polymorphism with bone mineral density in postmenopausal women with rheumatoid arthritis. Rheumatology (Oxford). 2005; 44:1067–1068.
Article
16. von Mühlen DG, Barrett-Connor E, Schneider DL, Morin PA, Parry P. Osteoporosis and apolipoprotein E genotype in older adults: the Rancho Bernardo study. Osteoporos Int. 2001; 12:332–335.
Article
17. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr. 2000; 71:1201–1208.
Article
18. Heikkinen AM, Kröger H, Niskanen L, Komulainen MH, Ryynänen M, Parviainen MT, et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women. Maturitas. 2000; 34:33–41.
Article
19. Stulc T, Ceska R, Horínek A, Stepán J. Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotype. Physiol Res. 2000; 49:435–439.
20. Schoofs MW, van der Klift M, Hofman A, van Duijn CM, Stricker BH, Pols HA, et al. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. J Bone Miner Res. 2004; 19:1490–1496.
Article
21. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371:1505–1512.
Article
22. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358:2355–2365.
Article
23. Rivadeneira F, Styrkársdottir U, Estrada K, Halldórsson BV, Hsu YH, Richards JB, et al. GEFOS) Consortium. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41:1199–1206.
Article
24. Gerdes LU, Vestergaard P, Hermann AP, Mosekilde L. Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women. J Bone Miner Res. 2001; 16:1906–1916.
Article
25. Macdonald HM, McGuigan FE, Lanham-New SA, Fraser WD, Ralston SH, Reid DM. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr. 2008; 87:1513–1520.
Article
26. Knapen MH, Hamulyák K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med. 1989; 111:1001–1005.
Article
27. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol. 2000; 20:2346–2348.
Article
28. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997; 17:680–687.
Article
29. Tong TY, Yong RY, Goh VH, Liang S, Chong AP, Mok HP, et al. Association between an intronic apolipoprotein E polymorphism and bone mineral density in Singaporean Chinese females. Bone. 2010; 47:503–510.
Article
30. Tolonen S, Mikkilä V, Laaksonen M, Sievänen H, Mononen N, Hernesniemi J, et al. Association of apolipoprotein E promoter polymorphisms with bone structural traits is modified by dietary saturated fat intake - the Cardiovascular Risk in Young Finns study. Bone. 2011; 48:1058–1065.
Article